Delivery Order SPE2DB20D1004-SPE2DB24FF3H8

Award Date 1/31/24
Potential Completion Date 2/1/24
Potential Value $2.2K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Citalopram HBR 40 mg tablets to the Defense Logistics Agency (DLA). The contract, valued at $1,613.37, was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is a Firm Fixed Price Delivery Order with a completion date of February 15, 2024. No set-aside designation was used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,474.36 firm fixed-price delivery order is for the supply of Citalopram HBr 40 mg tablets. The contract has an ultimate completion date of November 9, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award is for the delivery of Citalopram HBR 40mg tablets by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $6,323.48 firm-fixed-price delivery order was placed by the Defense Logistics Agency (DLA) on May 15, 2023, with a completion date of May 16, 2023. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to supply a comprehensive range...
This federal contract award is for the delivery of 4,564,010,669 units of Citalopram HBR 40 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,666.92, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The contract is a firm fixed price delivery order with a performance period through March 20, 2024. Amerisourcebergen Drug Corp has received numerous...
This federal contract award is for the delivery of 4,566,132,482 units of Citalopram HBR 20 mg tablets to the Defense Logistics Agency (DLA). The $3,376.23 fixed-price delivery order was awarded to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 18, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is for the delivery of 4564415425 units of Citalopram HBR 40 mg tablets to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The $2,138.93 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract has an ultimate completion date of April 29, 2024. Amerisourcebergen holds a significant Indefinite Delivery...
This federal contract award is for the delivery of CITALOPRAM HBR 40 MG TABLET 500S to the Defense Logistics Agency (DLA). The contract, valued at $22,947.85, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract is a Delivery Order with a Firm Fixed Price pricing type and runs through April 29, 2024. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Citalopram HBR 40 mg tablets. The $9,423.28 Firm Fixed Price Delivery Order has an ultimate completion date of July 12, 2024. This order is placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which provides a broad range of pharmaceutical products and medical supplies...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of parent company Cencora, Inc., was issued by the Defense Logistics Agency (DLA) for the delivery of Citalopram HBR 40 mg tablets. The $16,857.39 Firm Fixed Price Delivery Order has an ultimate completion date of February 15, 2024. The award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract worth $6,909.53 to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. This contract is for the delivery of Citalopram HBR 40 mg tablets in quantities of 500s to support military treatment programs and facilities. The contract has a completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a larger indefinite...
  • SPE2DB20D1004
    Indefinite Delivery Contract
  • SPE2DB20D1004-SPE2DB24FF3H8
    Delivery Order

This federal contract award is for the delivery of Citalopram HBR 40 mg tablets to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $2,244.13, and has an ultimate completion date of February 1, 2024. The contract was awarded on January 31, 2024, and there is no set-aside designation.

Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does business as Amerisourcebergen. Cencora, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, that runs through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare programs. Amerisourcebergen also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 2/27/25, 11:19 AM